Form 8-K - Current report:
SEC Accession No. 0001628280-21-024728
Filing Date
2021-12-09
Accepted
2021-12-09 06:31:52
Documents
23
Period of Report
2021-12-09
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K auph-20211209.htm   iXBRL 8-K 43037
2 EX-99.1 aurora2investorslides.htm EX-99.1 6908
6 GRAPHIC aurora2investorslides001.jpg GRAPHIC 82299
7 GRAPHIC aurora2investorslides002.jpg GRAPHIC 69859
8 GRAPHIC aurora2investorslides003.jpg GRAPHIC 96665
9 GRAPHIC aurora2investorslides004.jpg GRAPHIC 73966
10 GRAPHIC aurora2investorslides005.jpg GRAPHIC 82766
11 GRAPHIC aurora2investorslides006.jpg GRAPHIC 69858
12 GRAPHIC aurora2investorslides007.jpg GRAPHIC 65180
13 GRAPHIC aurora2investorslides008.jpg GRAPHIC 81632
14 GRAPHIC aurora2investorslides009.jpg GRAPHIC 69859
15 GRAPHIC aurora2investorslides010.jpg GRAPHIC 76320
  Complete submission text file 0001628280-21-024728.txt   1250072

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20211209.xsd EX-101.SCH 1942
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20211209_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20211209_pre.xml EX-101.PRE 12668
16 EXTRACTED XBRL INSTANCE DOCUMENT auph-20211209_htm.xml XML 10834
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36421 | Film No.: 211480229
SIC: 2834 Pharmaceutical Preparations